Tag Archives: WEX

Top Casino Stocks To Own For 2019

Warren Buffett warned students about the perils of using debt and leverage decades ago using Donald Trump as a negative case study.

Buffett was asked by a Notre Dame student about Trump’s business troubles during a question and answer session in 1991. Trump’s Atlantic City Taj Mahal casino filed for Chapter 11 bankruptcy protection later that year.

“Where did Donald Trump go wrong? The big problem with Donald Trump was he never went right. He basically overpaid for properties, but he got people to lend him the money. He was terrific at borrowing money. If you look at his assets, and what he paid for them, and what he borrowed to get them, there was never any real equity there,” Buffett said, according to a transcript published by former hedge fund manager Whitney Tilson. “I’ve seen more people fail because of liquor and leverage leverage being borrowed money. Donald Trump failed because of leverage. He simply got infatuated with how much money he could borrow, and he did not give enough thought to how much money he could pay back.”

Top Casino Stocks To Own For 2019: John B. Sanfilippo & Son, Inc.(JBSS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    BidaskClub upgraded shares of John B. Sanfilippo & Son (NASDAQ:JBSS) from a hold rating to a buy rating in a research note released on Wednesday.

  • [By Max Byerly]

    The Hershey (NYSE: HSY) and John B. Sanfilippo & Son (NASDAQ:JBSS) are both consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

  • [By Stephan Byrd]

    WINTON GROUP Ltd acquired a new position in shares of John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) in the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 21,466 shares of the company’s stock, valued at approximately $1,242,000. WINTON GROUP Ltd owned about 0.19% of John B. Sanfilippo & Son at the end of the most recent quarter.

Top Casino Stocks To Own For 2019: FS Bancorp, Inc.(FSBW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    FS Bancorp (NASDAQ:FSBW) – Research analysts at FIG Partners boosted their Q2 2018 earnings estimates for FS Bancorp in a research report issued to clients and investors on Thursday, May 3rd. FIG Partners analyst T. Coffey now anticipates that the bank will post earnings per share of $1.16 for the quarter, up from their prior forecast of $1.13. FIG Partners also issued estimates for FS Bancorp’s FY2018 earnings at $4.70 EPS, Q1 2019 earnings at $1.08 EPS, Q4 2019 earnings at $1.33 EPS and FY2019 earnings at $5.09 EPS.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on FS Bancorp (FSBW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    FS Bancorp (NASDAQ: FSBW) and Anchor (NASDAQ:ANCB) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on FS Bancorp (FSBW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Casino Stocks To Own For 2019: Enpro Industries(NPO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    New York State Common Retirement Fund grew its holdings in EnPro Industries, Inc. (NYSE:NPO) by 19.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,168 shares of the industrial products company’s stock after purchasing an additional 5,888 shares during the quarter. New York State Common Retirement Fund owned approximately 0.17% of EnPro Industries worth $2,799,000 at the end of the most recent quarter.

  • [By Max Byerly]

    News coverage about EnPro Industries (NYSE:NPO) has been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. EnPro Industries earned a daily sentiment score of 0.07 on Accern’s scale. Accern also gave news articles about the industrial products company an impact score of 46.9443513305379 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Top Casino Stocks To Own For 2019: WEX Inc.(WEX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on WEX (WEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Performing Stocks To Invest In 2019

Boeing Co.’s (NYSE: BA) share price added about 2.8% last week to maintain its position as the best performing among the 30 stocks that make up the Dow Jones Industrial Average (DJIA). Shares gained $8.04 last week to boost the year-to-date gain to nearly 89%.

Of the three other stocks closest to Boeing’s yearly gain, Caterpillar Inc. (NYSE: CAT) rose by about 1.9% to a gain of over 58% for the year, Apple Inc. (NASDAQ: AAPL) added about 2.7% to close the week up just over 50% for the year to date and Visa Inc. (NYSE: V) tacked on 1.8% to bring its annual gain to nearly 46%.

Last week was a busy one for Boeing, at least for its public affairs staff. The company raised its dividend, approved a new share buyback program, lost a military jet order to Canada, lost a multibillion passenger jet order to arch-rival Airbus and then read the news about the shake-up at the top of its European competitor.

As expected, Boeing lifted its dividend following Monday’s board of directors meeting. The 20% increase, from $5.68 to $6.84 annually per share, was accompanied by a new share repurchase plan valued at $18 billion. The company posted a new 52-week high on Tuesday.

Top 5 Performing Stocks To Invest In 2019: DoubleLine Opportunistic Credit Fund(DBL)

Advisors’ Opinion:

  • [By Logan Wallace]

    Doubleline Opportunistic Credit Fund common stock (NYSE:DBL) announced a monthly dividend on Friday, June 1st, Zacks reports. Investors of record on Thursday, June 14th will be paid a dividend of 0.167 per share by the investment management company on Friday, June 29th. This represents a $2.00 dividend on an annualized basis and a yield of 9.41%. The ex-dividend date is Wednesday, June 13th.

  • [By Max Byerly]

    News headlines about Doubleline Opportunistic Credit Fund common stock (NYSE:DBL) have been trending somewhat positive on Monday, according to Accern Sentiment. Accern identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Doubleline Opportunistic Credit Fund common stock earned a news impact score of 0.04 on Accern’s scale. Accern also gave media stories about the investment management company an impact score of 47.2090833571026 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Top 5 Performing Stocks To Invest In 2019: Cray Inc(CRAY)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Gardner:There’sa lot of biotech and some computer companies. We once visited the Cray Corporation (NASDAQ:CRAY), which was one of the early supercomputer companies.Seymour Cray was one of the pioneers of supercomputing. If you look up Cray Computers, they were the supercomputers back in the 80s, when computers were a lot bigger than they are today, andprobably slower, but they were super back then. Anyway,that was a Minneapolis company I once visited. Our dad used to take us, occasionally, on trips. We’d just drop by corporate headquarters and talk to an investor relations person. That was one of the times I did that. Itwasn’t like I did it dozens of times. We did maybe five or six times. ButI’ll always remember Cray Computer.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Cray (CRAY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Performing Stocks To Invest In 2019: WEX Inc.(WEX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on WEX (WEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Performing Stocks To Invest In 2019: John Hancock Financial Opportunities Fund(BTO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    CIBC World Markets Inc. reduced its holdings in B2Gold Corp. (NYSEAMERICAN:BTG) (TSE:BTO) by 10.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 572,525 shares of the basic materials company’s stock after selling 64,714 shares during the period. CIBC World Markets Inc. owned approximately 0.06% of B2Gold worth $1,563,000 as of its most recent SEC filing.

Top 5 Performing Stocks To Invest In 2019: WellCare Helath Plans Inc.(WCG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Federated Investors Inc. PA lessened its holdings in WellCare (NYSE:WCG) by 17.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 50,260 shares of the company’s stock after selling 10,275 shares during the period. Federated Investors Inc. PA owned about 0.11% of WellCare worth $9,732,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on WellCare Health Plans (WCG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    WellCare (NYSE:WCG) had its target price boosted by Wells Fargo from $220.00 to $240.00 in a report released on Wednesday morning. Wells Fargo currently has an outperform rating on the stock.

  • [By Logan Wallace]

    The Manufacturers Life Insurance Company lowered its position in shares of WellCare Health Plans, Inc. (NYSE:WCG) by 3.4% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 71,193 shares of the company’s stock after selling 2,528 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in WellCare Health Plans were worth $13,785,000 as of its most recent filing with the SEC.

Top Stocks For 2019

twenty20.com/@ajknapp

By Esther Crain

This story originally appeared on LearnVest as “Half the Country Got Raises This Year. Here’s What to Do if You Didn’t.”

As the heated fallout over the 2016 election revealed, Americans are split almost 50-50 by their politics.

But there’s another divide cleaving the country into halves as well: a gap in who received a pay hike this year.

RELATED: 3 Workplace Trends That Could Affect Your Future Paycheck

Nearly 50% of all working Americans reported that their salary increased in the past 12 months, according to a November survey from Bankrate. Of the workers who said they were pulling in more money, a little over a third of them attributed it to a pay raise—mostly due to a performance-based raise, cost-of-living salary adjustment or promotion. The other 12% said their income jumped because they left their job and secured a higher-paying position elsewhere.

Top Stocks For 2019: ABAXIS Inc.(ABAX)

Advisors’ Opinion:

  • [By Shane Hupp]

    Abaxis (NASDAQ:ABAX) saw some unusual options trading on Thursday. Stock traders bought 1,103 call options on the stock. This is an increase of 1,905% compared to the typical daily volume of 55 call options.

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st
  • [By Lisa Levin] Gainers
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 15.6 percent to $25.40 in pre-market trading after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Abaxis, Inc. (NASDAQ: ABAX) rose 15.3 percent to $82.75 in pre-market trading. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) rose 12.6 percent to $8.95 in pre-market trading after reporting Q1 results.
    Micro Focus International plc (NYSE: MFGP) shares rose 8.8 percent to $18.59 in the pre-market trading session after the company issued strong revenue forecast for the first fiscal half of 2018.
    HC2 Holdings, Inc. (NASDAQ: HCHC) rose 5.6 percent to $6.60 in pre-market trading.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares rose 5.3 percent to $2.79 in pre-market trading. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) rose 5.2 percent to $2.52 in pre-market trading after reporting a first-quarter sales beat.
    Red Violet, Inc. (NASDAQ: RDVT) rose 4.1 percent to $10.35 in pre-market trading after climbing 75.31 percent on Tuesday.
    Xenon Pharmaceuticals Inc (NASDAQ: XENE) rose 3.8 percent to $6.90 in pre-market trading. The stock rose over 10 percent Tuesday after reporting its Phase 1 clinical update on XEN901 demonstrated a favorable PK profile.
    Sea Limited (NYSE: SE) rose 3.5 percent to $11.01 in pre-market trading after reporting Q1 results.
    Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares rose 3.4 percent to $20.98 in pre-market trading after Buffett's Berkshire more than doubled its stake in Teva.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 3.7 percent to $31.30 in pre-market trading after the company reported results for its fourth quarter.
    PetIQ Inc (NASDAQ: PETQ) shares rose 3.4 percent to $20.00 in pre-market t
  • [By Chris Lange]

    Abaxis Inc. (NASDAQ: ABAX) shares hit an all-time high early on Wednesday after it was announced that Zoetis Inc. (NYSE: ZTS) would be acquiring the firm. The acquisition is expected to enhance Zoetis presence in veterinary diagnostics, a category of the animal health industry with approximately 10% compound annual growth over the past three years.

  • [By Stephan Byrd]

    Abaxis (NASDAQ:ABAX)’s share price reached a new 52-week high and low during trading on Wednesday . The stock traded as low as $83.24 and last traded at $83.09, with a volume of 174316 shares changing hands. The stock had previously closed at $82.35.

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares climbed 31.68 percent to close at $7.19 on Wednesday. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares gained 24.15 percent to close at $3.29. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    21Vianet Group, Inc. (NASDAQ: VNET) shares surged 24 percent to close at $6.82.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 20.25 percent to close at $4.87.
    HUYA Inc. (NYSE: HUYA) shares surged 18.42 percent to close at $22.50
    Abaxis, Inc. (NASDAQ: ABAX) rose 16.15 percent to close at $83.34. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Pain Therapeutics, Inc. (NASDAQ: PTIE) shares jumped 16.07 percent to close at $10.62.
    Bilibili Inc. (NASDAQ: BILI) rose 16.04 percent to close at $14.11.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) gained 14.88 percent to close at $6.33.
    Phoenix New Media Limited (NYSE: FENG) rose 13.96 percent to close at $5.55.
    Daqo New Energy Corp. (NYSE: DQ) jumped 13.88 percent to close at $67.27 on Wednesday.
    Sea Limited (NYSE: SE) jumped 12.59 percent to close at $11.98 after reporting Q1 results.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 12.01 percent to close at $5.13.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) gained 11.93 percent to close at $3.19.
    Boot Barn Holdings, Inc. (NYSE: BOOT) climbed 11.66 percent to close at $24.52 on Wednesday after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Macy's, Inc. (NYSE: M) rose 10.83 percent to close at $33.17 after the company reported stronger-than-expected results for its first quarter and lifted guidance.
    ChemoCentryx, Inc. (NASDAQ: CCXI) gained 9.36 percent to close at $12.50. Canaccord Genuity initiated coverage on ChemoCentryx with a Buy rating.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX)

Top Stocks For 2019: Real Goods Solar, Inc.(RGSE)

Advisors’ Opinion:

  • [By Paul Ausick]

    Real Goods Solar Inc. (NASDAQ: RGSE) traded down 7.5% Monday to set a new 52-week low of $0.37 after closing Friday at $0.40. The stock’s 52-week high is $3.25. Volume was more than 13 times the daily average of about 678,000 shares. The company had no specific news, but a report on solar energy prospects for 2018 may have weighed on the stock.

Top Stocks For 2019: WEX Inc.(WEX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on WEX (WEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

best securities to invest in

The Mexican peso is headed for its largest monthly gain in nearly five years as President Donald Trump and his partisans suffer the first major legislative setback of his presidency.

This looming milestone represents drastic and, many believed, improbable, turnaround for the peso, the most heavily traded currency in Latin America: Two months ago, just as Trump was preparing to take the oath of office, the currency plunged to an all-time low. It has risen nearly 10% against the dollar since then, and since the beginning of March, the greenback has slid nearly 7% against the peso.

best securities to invest in: China Automotive Systems, Inc.(CAAS)

Advisors’ Opinion:

  • [By Monica Gerson]

    China Automotive Systems, Inc. (NASDAQ: CAAS) is projected to post its quarterly earnings at $0.20 per share on revenue of $108.22 million.

    Affimed NV (NASDAQ: AFMD) is projected to post a quarterly loss at $0.18 per share on revenue of $1.71 million.

best securities to invest in: Cyclacel Pharmaceuticals Inc.(CYCC)

Advisors’ Opinion:

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

best securities to invest in: WEX Inc.(WEX)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

best securities to invest in: Eli Lilly and Company(LLY)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Both Evenity and Tymlos are anabolic treatments, which means they encourage bone growth, rather than merely preventing bones from becoming more brittle, as prior generation osteoporosis drugs have done. While Eli Lilly (NYSE:LLY) was the first to market a drug in this class when Forteo gained marketing approval in 2002, it has faced no competitors despite achieving $1.5 billion in global sales last year, including $770 million in the United States. All of its patents expire by August 2019.

  • [By Keith Speights]

    With this rapidly growing market, there are plenty of opportunities for investors. Zoetis (NYSE:ZTS), Merck (NYSE:MRK), and Eli Lilly (NYSE:LLY) stand out as the top animal-health companies to buy in 2017. Here’s why.

  • [By WWW.THESTREET.COM]

    Cramer recalled recently investing in Eli Lilly (LLY) on hopes the company’s Alzheimer’s research would be worth billions. As time has worn on, Lilly’s obstacles to success seem to be mounting. Not knowing if or when Lilly might see success, Cramer said he sold the stock and moved on.

  • [By WWW.THESTREET.COM]

    Bond prices were much lower early in the day, with yields up by nearly 10 basis points. But fixed income has rallied back (reducing the drop by half on the day). Valeant Pharmaceuticals (VRX) , more weakness. Large pharma lower, led by Eli Lilly (LLY) . Old tech lags, with International Business Machines (IBM) , Intel (INTC) , Cisco Systems (CSCO) and Microsoft (MSFT) all lower. Media roughed up a bit (CBS (CBS) and Comcast (CMCSA) ). The Ugly
    Gold down another $23 to $1,188 (SPDR Gold Trust ETF (GLD) down $2.25). Urban Outfitters (URBN) down $5. NOTE: There will be no “Takeaways” today!   Happy Thanksgiving. Position: Long GLD small, SDS large, JCP large; short SPY, CSCO, CAT small, IWM, TLT small.

  • [By Ben Levisohn]

    Following the decision of the PTAB not to institute CHRS IPR on the 166 Humira formulation patent, we continue to anticipate that first likely launch of biosimilar adalimumab (Humira) in the US will be delayed until 2020, in line with our published forecasts and biosimilar model. We anticipate the open IPR hearings for the 135 dosing patent on Humira (filed by Boehringer and Coherus) to begin in Feb 2017 with the ruling in May. We rateAbbVie a Buy. We continue to prefer BUY rated Bristol-Myers Squibb (BMY), Eli Lilly (LLY) among the US names.

  • [By Johanna Bennett]

    Eli Lilly & Co. (LLY) and Biogen (BIIB) are far from the only two drug makers racing to deliver a new treatment for Alzheimers disease. But they are pretty much leading the pack.

    The market for an effective therapy that actually slows the progression of the disease would likely generate billions of dollars in annual sales. It is quite literally the drug industrys version of the holy grail.

    And according to Barclays analysts Geoff Meacham and Paul Choi, the next few weeks could prove to be one of the most fertile periods in Alzheimers disease research since 2008.

    We think the most likely outcome for Lilly’s Phase 3 EXPEDITION 3 (E3) solanezumab trial is the primary cognition (ADAS-Cog14) endpoint is met (just achieving statistical significance with a p-value <0.05) and mixed results on the secondary endpoints including function (ADL), which we believe should be good enough to support a regulatory submission. While aducanumab has a marginally different mechanism of action, we nevertheless expect BIIB shares to trade in sympathy to Lilly.

    Implications for Biogen and Merck: The E3 results are likely to result in volatility for Biogen (up 20-30%, down 10-15%) as Alzheimer’s drives both long-term growth and M&A value even though aducanumab works differently from solanezumab.

    Aducanumab dose titration data is expected at the CTAD meeting (San Diego, Dec. 9). Merck’s Phase 2/3 EPOCH verubecestat (BACE) trial is scheduled to finish in June 2017 but unlike E3, PET scans/CSF tests for A were not an inclusion criteria. We think Merck shares could move 3% to 5% in either direction in sympathy to E3.

    At $76.58, Lillys share price has fallen more than 9% over the past year, while Biogen has climbed more than 9% over the same span.

best securities to invest in: Superior Drilling Products, Inc.(SDPI)

Advisors’ Opinion:

  • [By Money Morning News Team]

    Superior Drilling Products Inc.(NYSE: SDPI) is based in Utah and manufactures equipment used in drilling for the natural gas and oil mining sectors.